PRN: POC Diagnostics Market Forecast 2017-2027

18/set/2017 15:15:23 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

POC Diagnostics Market Forecast 2017-2027

 
[18-September-2017]
 

LONDON, September 18, 2017 /PRNewswire/ --

Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies

POC Diagnostics - our new study reveals trends, R&D progress, and predicted revenues: 

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Where is the POC Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead: 

Our 289-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing POC Diagnostics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects: 

• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets: 

Along with revenue prediction for the overall world market, there are forecasts for 7 POC Diagnostics Types, each forecasted at a global level.

POC Diagnostics, by Product Type: 

• Blood Glucose
• Infectious Diseases
• Rapid Coagulation
• Rapid Cardiac Marker
• Cholesterol
• Pregnancy
• Other

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 15 leading national markets:
• The US
• Germany
• The UK
• Italy
• Spain
• France
• Switzerland
• Belgium
• The Netherlands
• Japan
• China
• India
• Brazil
• Russia
• South Africa
• RoW

The report also includes profiles and for some of the leading companies in the POC Diagnostics market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Japan in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth: 

Overall world revenue for POC Diagnostics will surpass $5bn in 2027, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the POC Diagnostics Market report helps you: 

In summary, our 289-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the POC Diagnostics market with forecasts for 7 Types of POC testing - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 15 key national markets - See forecasts for the POC Diagnostic market in the US, Japan, Germany, France, the UK, Italy, Spain, Belgium, The Netherlands, Switzerland, Brazil, China, India, South Africa and Russia
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 4 of the major companies involved in the POC Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else: 

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the POC Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today POC Diagnostic Systems Market Forecast 2017-2027: Analysis of POC Diagnostics Market Forecast 2017-2027: Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com  or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/1993/POC-Diagnostics-Market-Forecast-2017-2027

Companies Mentioned in the Report 

3M

Abaxis

Abaxis Inc

Abbott Cardiovascular Inc

Abbott Diabetes Care

Abbott Molecular Inc.

Abbott Point of Care

Abbott S.r.l.

Abbott SA

Advanced Care

Affymetrix, Inc.

AgaMatrix

Agendia BV

Alere Health Systems Inc.

Alere Medical Japan

Amgenix International Inc

Arkay

Ascensia Diabetes Care

Astra Zeneca

AutoGenomics, Inc.

Avioq, Inc.

B Braun

Bayer

BBI Helathcare

Becton Dickinson

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd

Biofire Diagnostics

BioLytical Laboratories

Bionime

Bio-Rad Laboratories

Biosense Medical

BioSign

Biosite Diagnostics

Biosynex Medtech

Boehringer Ingelheim

Calypte Biomedical

Celera Diagnostics

Cepheid

Cerus Corporation

Chembio Diagnostic Systems

Cholestech

Church & Dwight

Clinical Micro Sensors, Inc.

Concateno

Core Diagnostics

CVS/Pharmacy

Dako Denmark A/S

DakoCytomation Denmark A/S

Dario Health

Decision Diagnostics Corp.

Dexcom

Diabetic Supply of Suncoast

Diagnostic Devices

DiME

Early Pregnancy Tests.com

EKF Diagnostics

Entra Helath Systems

Exact Sciences Corporation

EY Laboratories

Fenwal Inc

Fifty50 Medical

Focus Diagnostics

ForaCare

Fujirebio

Genentech

General Life Biotechnology Ltd

Genesis Health Technology

GenMark Diagnostics

Gen-Probe, Inc.

Genzyme

Gluco Com

Grove Instruments

Halifax

Helena Laboratories

Hema technologies

Hologic, Inc.

Home Access Health Corporation

Horiba

IHelath Labs

Illumina, Inc.

IME-DC

IND Diagnostic Inc.

Infopia

Insight Pharmaceuticals

Instrumentation Laboratory (a company of Werfen Group)

InTec Products

Integrity Applications Ltd.

International Technidyne Corporation

Inverness Medical

Iris Molecular Diagnostics

JANT Pharmacal Corporation

Johnson & Johnson

LifeScan

Livongo Health

Luminex Molecular Diagnostics, Inc.

Marnes La Coquette

Maxim Biomedical Inc

Medford

Medix Biochemica

Medor

Menarini

Meridian Bioscience

Mitsubishi Chemical

MIZUHO MEDY Company

Myriad Genetic Laboratories, Inc.

Nani Daman

Nanosphere, Inc.

Nanostring Technologies

Nipro Diadnostics

Nova Diabetes

Oak Tree Health

Oak Tree International Holdings

Omnis Health

One Drop

OraSure Technologies

Orgenics

OrSense NBM-200G

Ortho-Clinical Diagnostics, Inc.

Osmetech Molecular Diagnostics

ParagonDx, LLC

Partec

Pathwork Diagnostics Inc.

Pharma Tech Solutions

Philosys

POC Medical System

PointCare Technologies

Polymer Technology Systems Inc

Premier Medical Corporation

Princeton Biomedtech

Procter & Gamble

Prodigy Diabetes Care

Proteome Systems

Quest Diagnostics

Quidel

Remel/Thermofisher

Response Biomedical Corporation

Roche Diagnostics Corporation

Roche Molecular Systems, Inc.

RunBio Biotech Company

SA Scientific

Sanofi

Savyon Diagnostics

Sedia Biosciences Corporation, USA

Sekisui Medical Company

Shanghai Kehua Bioengineering Co., Ltd.

Siemens Financial Services GmbH

Siemens Healthcare Diagnostics GmbH

Siemens Healthcare Diagnostics SA

Siemens Healthcare EOOD

Siemens Healthineers

Spartan Bioscience, Inc.

Spirit Healthcare

Standard Diagnostics Inc.

Swiss Precision Diagnostics

Symphony

Sysmex

Target

Telcare

Thermo Fisher Scientific

Third Wave Technologies Inc.

Tm Bioscience Corporation

TrimGen Corporation

Trinity Biotech

Trividia Health

Trovagene

U.S. Diagnostics

Unimed International

Universal Biosensors

Universal Diagnostics

Ventana Medical Systems, Inc.

Veridex, LLC.

Vysis

Walgreens

Walmart

WellDoc Corporation

xDx Inc.

YD Diagnostics

Ypsomed

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl